Gene · 26585
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Omics Analysis Reveals the Molecular Subtypes and Confirmed the GREM1 as the Core Gene. | J Gene Med | 2026 | 41494662 | PubTator, text mining | PubMed |
| Gremlin-1 is associated with obesity but not polycystic ovary syndrome: Insights from a body mass index-matched analysis of bone morphogenetic protein pathway components, a cross-sectional study. | Int J Gynaecol Obstet | 2026 | 41369015 | PubTator, text mining | PubMed |
| Gremlin1-MSCs seeded on small-diameter artificial blood vessels facilitate attenuation of post-transplantation intimal hyperplasia. | Biomaterials | 2026 | 41260110 | PubTator, text mining | PubMed |
| Tumor-intrinsic dichotomy shapes cellular heterogeneity in pancreatic cancer. | Trends Cancer | 2026 | 41241613 | PubTator, text mining | PubMed |
| Integrated longitudinal transcriptomic and proteomic analysis of the murine lung response to influenza a virus. | Am J Respir Cell Mol Biol | 2026 | 41072037 | PubTator, text mining | PubMed |
| Comparable expression of stem markers and damage-responsive proteins in untreated and chemoradiation-treated rectal cancer. | Histol Histopathol | 2026 | 41039949 | PubTator, text mining | PubMed |
| Expression of TGFB1 and ERK in cumulus cells: Implications for oocyte maturation in women with polycystic ovary syndrome: A cross-sectional study. | Int J Reprod Biomed | 2025 | 41783728 | PubTator, text mining | PubMed |
| Fueling the Seed: Growth Factors and Cytokines Driving Cancer Stem Cells in Gynecological Malignancies. | Int J Mol Sci | 2025 | 41373619 | PubTator, text mining | PubMed |
| Synergizing biomaterials and cellular molecular pathways: a new frontier in hair follicle generation. | J Transl Med | 2025 | 41345670 | PubTator, text mining | PubMed |
| Inhibition of Gremlin1 reduces osteoclast activation and alleviates inflammation-induced bone loss by disrupting the NF-κB signaling pathway. | J Oral Biosci | 2025 | 41274692 | PubTator, text mining | PubMed |
| Fibroblastic FLT3L supports lymph node dendritic cells in the interfollicular niche. | Nat Immunol | 2025 | 41249485 | PubTator, text mining | PubMed |
A Comparative Analysis of Gremlin-1 (GREM1), Hyaluronic Acid Synthetase-2 (HAS2), and Prostaglandin-Endoperoxide Synthase-2 (PTGS2) Expression in Cumulus Cells Among Women with Diminished Ovarian Reserve Following Rescue In Vitro Maturation (r-IVM). | Life (Basel) | 2025 | 41157281 | PubTator, text mining | PubMed |
| Causal effects and mediation pathways of circulating plasma proteins on osteoporosis: a two-sample and two-step Mendelian randomization study. | Clin Proteomics | 2025 | 41107716 | PubTator, text mining | PubMed |
| Integrated transcriptome and metabolome analysis of E17 embryonic pectoral muscle development regulated by 1 % CO2 during the first 10 days of incubation. | Poult Sci | 2025 | 41086770 | PubTator, text mining | PubMed |
| Bone morphogenetic protein signaling pathway: an essential role in intestinal homeostasis and diseases. | Cell Mol Biol (Noisy-le-grand) | 2025 | 41054374 | PubTator, text mining | PubMed |
| Interpretable artificial intelligence based on immunoregulation-related genes predicts prognosis and immunotherapy response in lung adenocarcinoma. | Front Bioinform | 2025 | 41048340 | PubTator, text mining | PubMed |
| Identification of a novel GREMLIN1 uptake pathway in epithelial cells that requires BMP binding. | J Biol Chem | 2025 | 41033552 | PubTator, text mining | PubMed |
| Exploring the Cellular and Molecular Landscape of Idiopathic Pulmonary Fibrosis: Integrative Multi-Omics and Single-Cell Analysis. | Biomedicines | 2025 | 41007698 | PubTator, text mining | PubMed |
| The Colonic Crypt: Cellular Dynamics and Signaling Pathways in Homeostasis and Cancer. | Cells | 2025 | 41002393 | PubTator, text mining | PubMed |
| SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. | Nature | 2025 | 40993391 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26585/papers?page=4